nPOD Meeting Agenda

Tentative Meeting Agenda

Alberto Pugliese, MD, Mark Atkinson PhD, and Carmella Evans-Molina MD, PhD
nPOD Executive Directors

Co-Chairs: TBA


Clinical and Laboratory Features of T1D According to Age of Diagnosis (1:45 PM – 2:10 PM)

Presenter: Kathleen Gillespie, PhD


Age and Genetic Correlates (2:10 PM – 2:35 PM)

Presenter: Nick Thomas, PhD
View Biography


Immunological Characteristics of T1D According to Age (2:35 PM – 3:00 PM)

Presenter: Alice Long, PhD
View Biography

Led by: TBA

Co-Chairs: TBA


Prohormone Processing Defects in T1D (4:15 PM – 4:40 PM)

Presenter: Peter Arvan, MD PhD
View Biography


Quantification of Beta Cells by DNA Methylation (4:40 PM – 5:05 PM)

Presenter: Zeina Drawshy, MS


Oxidized Insulin Epitopes in T1D  (5:05 PM – 5:30 PM)

Presenter: Rocky Strollo, MD PhD
View Biography

Led by: TBA

Interdicting Type 1 Diabetes – A 40 Year Perspective

Presenter: Jay Skyler, MD
View Biography

Light hors d’oeuvres provided

Led by: Mark Huising, PhD

Cutting Edge Methods for the Design of Novel Therapeutics

Presenter: John Williams, PhD

Co-Chairs: TBA


Exocrine Pancreas in T1D: Gene Expression Studies (9:15 AM – 9:40 AM)

Presenter: Kyle Gaulton, PhD
View Biography


Exocrine Pancreas Development: Any Alterations in T1D? (9:40 AM – 10:05 AM)

Presenter: Marcella Brissova, PhD


Functional Assessment of Exocrine Function in T1D (10:05 AM – 10:30 AM)

Presenter: Stephan Speier, PhD

Led by: TBA

Co-Chairs: TBA


TBA (11:45 AM – 11:55 AM)

Presenter: TBA


TBA (11:55 AM – 12:05 PM)

Presenter: TBA


TBA (12:05 PM – 12:15 PM)

Presenter: TBA

Led by: Klaus Kaestner, PhD
View Biography

Co-Chairs: TBA


Pancreas Slice Live Tissue Platforms Overview, Pros and Cons, Ongoing & Potential Applications I (1:30 PM – 1:55 PM)

Presenter: Julia Panzer, PhD
View Biography


Ongoing & Potential Applications II (1:55 PM – 2:20 PM)

Presenter: Ed Phelps, PhD
View Biography


Artificial Organ Platforms for T1D (2:20 PM – 2:45 PM)

Presenter: Matthias von Herrath, MD


Advanced Humanized Mice Platforms for Modeling T1D and Response to Therapy (2:45 PM – 3:10 PM)

Presenter: Audrey Parent, PhD
View Biography

Led by: TBA

Co-Chairs: TBA


TBA (4:25 PM – 4:35 PM)

Presenter: TBA


TBA (4:35 PM – 4:45 PM)

Presenter: TBA


TBA (4:45 PM – 4:55 PM)

Presenter: TBA


TBA (4:55 PM – 5:05 PM)

Presenter: TBA

Includes annual meeting photos during California sunset
Sunset predicted at 5:41 PM – please meet at 5:30 PM

Organized by: Alberto Pugliese, MD

Led by: TBA

Co-Chairs: TBA


Many Antigen Targets, Which Ones Matter? (8:30 AM – 8:55 AM)

Presenter: Roberto Mallone, MD PhD


Antigen Specific Cell Therapies (8:55 AM – 9:20 AM)

Presenter: Qizhi Tang, PhD
View Biography


Autoantigens and Neoantigens: Current Status and Relevance to Prediction and Prevention (9:20 AM – 9:45 AM)

Presenter: Aaron Michels, MD
View Biography

Led by: TBA

Shark Tank III (now with Piranhas)

Sharks: TBA
Piranhas: TBA


TBA (11:15 AM – 11:30 AM)


TBA (11:30 AM – 11:45 AM)


TBA (11:45 AM – 12:00 PM)


TBA (12:00 PM – 12:15 PM)


Audience Response (12:15 PM – 12:45 PM)

Led by: Mark Huising, PhD

Co-Chairs: TBA


Racial Diversity in T1D Clinical Trials (3:30 PM – 3:55 PM)

Presenter: Susanne Cabrera, MD


Racial Diversity in T1D Versus T2D (lessons from Discover Study) (3:55 PM – 4:20 PM)

Presenter: Maria Redondo MD, PhD, MPH


T1D Racial Diversity: Lessons From the TEDDY Study (4:20 PM – 4:45 PM)

Presenter: TBA

Led by: TBA

Hors d’oeuvres provided

Hotel checkout is 11 AM.

If checking out today, please bring luggage to the back of the meeting room for the remainder of the meeting.

Co-Chairs: TBA


TBA (9:00 AM – 9:10 AM)

Presenter: TBA


TBA (9:10 AM – 9:20 AM)

Presenter: TBA


TBA (9:20 AM – 9:30 AM)

Presenter: TBA


TBA (9:30 AM – 9:40 AM)

Presenter: TBA

Co-Chairs: TBA

Alberto Pugliese, MD, Mark Atkinson PhD, and Carmella Evans-Molina MD PhD
nPOD Executive Directors